Navigation Links
NewCardio Announces Positive Results From Third Clinical Validation Study
Date:8/13/2008

so anticipate developing an interface to discuss these important and compelling clinical validation data with drug regulators. We will soon augment our senior management team in an effort to add sales and marketing leadership to accelerate the commercialization initiative."

About QTinno(TM)

QTinno(TM) is a software suite that provides automated, comprehensive analysis of QT intervals and other ECG-based cardiac safety for the pharmaceutical industry and drug regulators. Its key features include full automation with minimal to no human intervention required, greatly improving the productivity, accuracy and precision of clinical trials. NewCardio believes QTinno(TM) is equal to the best manual assessments and is able to provide high-quality quantitative data from a broad range of difficult-to-read ECGs.

About NewCardio, Inc.

NewCardio is a cardiac diagnostic and services company focused on the development of a proprietary platform technology to provide higher accuracy to, and increase the value of, the standard 12-lead electrocardiogram (ECG). NewCardio's development-stage software and hardware products and services are intended to improve the diagnosis and monitoring of cardiovascular disease (CVD), as well as cardiac safety assessment of drugs under development. NewCardio's three-dimensional ECG platform is designed to reduce the time and expense involved in assessing cardiac status while increasing the ability to diagnose clinically significant conditions which were previously difficult to detect. For more information, visit http://www.newcardio.com.

Forward-Looking Statements

This press release contains forward-looking statements. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. T
'/>"/>

SOURCE NewCardio, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus
2. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases
3. Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma
4. Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
5. Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain
6. Amicus Therapeutics Announces Second Quarter 2008 Financial Results
7. Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule
8. Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences
9. Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial
10. Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-PD-L1 Antibody, MDX-1105
11. Cara Therapeutics Announces Successful Completion of Phase I Clinical Trial of Novel Analgesic, CR845
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... 24, 2013 The potential of ... delivery of therapeutic agents has been receiving undeniable attention ... showing significant promise. The crucial formulation considerations for orally ... play a major role in the efficiency of pulmonary ... development of new formulation techniques and devices in recent ...
(Date:5/23/2013)... DIEGO , May 23, 2013 Neurocrine Biosciences, ... Kevin Gorman , President and Chief Executive Officer ... 38 th Annual dbAccess Health Care Conference in Boston.   ... May 30 at 11:20 a.m. Eastern Time / 8:20 a.m. ... accessed on the Company,s website at http://www.neurocrine.com . ...
(Date:5/23/2013)... , May 23, 2013  MGC Diagnostics Corporation ... global medical technology company, today scheduled a conference call ... of fiscal year 2013, ended April 30, 2013. The ... May 30, 2013. The Company will report financial results ... the markets close on Thursday, May 30, 2013. ...
Breaking Medicine Technology:Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2
... 22, 2011 Regeneron Pharmaceuticals, Inc. (NASDAQ: ... Food and Drug Administration (FDA) has accepted for review ... Injection for Subcutaneous Use for the prevention of gout ... Prescription Drug User Fee Act (PDUFA), the goal for ...
... Endoscopy, Inc.,s (OTCPK: SNDY) is pleased to announce that ... of $73,895.  Solos Endoscopy has consummated agreements which resulted ... Three Months period ending September 30, 2011.  The signed ... reduction of ongoing expenses by approximately $40,000 per quarter. ...
Cached Medicine Technology:Regeneron Announces FDA Acceptance of ARCALYST® (rilonacept) Supplemental Biologics License Application for Review 2Regeneron Announces FDA Acceptance of ARCALYST® (rilonacept) Supplemental Biologics License Application for Review 3Regeneron Announces FDA Acceptance of ARCALYST® (rilonacept) Supplemental Biologics License Application for Review 4Regeneron Announces FDA Acceptance of ARCALYST® (rilonacept) Supplemental Biologics License Application for Review 5Regeneron Announces FDA Acceptance of ARCALYST® (rilonacept) Supplemental Biologics License Application for Review 6Regeneron Announces FDA Acceptance of ARCALYST® (rilonacept) Supplemental Biologics License Application for Review 7Regeneron Announces FDA Acceptance of ARCALYST® (rilonacept) Supplemental Biologics License Application for Review 8Solos Endoscopy Finishes the 3rd Quarter With a Net Profit 2
(Date:5/25/2013)... 2013 Many orthodontists have thought about ... exactly that cloud is. Most people would naturally ... to provide their cloud service and support would own ... service they're selling, they'd be wrong. Cloud providers ... secure, redundant facility that houses servers and related equipment ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 According to ... most beautiful and powerful women that ever lived. Cleopatra’s ... by some of the most powerful men in her ... beauty remedies to keep her skin glowing and fresh, ... with bees- wax, maringa oil and cyprus grass. , ...
(Date:5/25/2013)... The Slim Weight Patch has been clinically ... is due to the highly sought after ingredients that have ... offers an extra 2 months supply & premium membership of ... the body you desire faster than ever. , Click ... With Slim weight patch consumers can observe instant results within ...
(Date:5/25/2013)... Prairie Living at Chautauqua , ... American Red Cross Blood Drive from 1:30 to 5:30 ... is located at 955 Villa Ct. in Carbondale, Illinois, ... Medicaid, who need some help to maintain their independence.. ... Andrea Arview Frey, Director of Marketing for Prairie Living. ...
(Date:5/25/2013)... May 25, 2013 Ayurveda is ... or wisdom of life". While a medical science, its scope ... of consciousness. Its fundamental philosophy is that disease is the ... In order to re-establish optimal health, one must discover where ... life style which brings us back into perfect harmony. , ...
Breaking Medicine News(10 mins):Health News:Cirrus Ortho Launches Cloud Computing for Orthodontic Industry That is Unlike Any Other 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3Health News:Slim Weight Patch Advanced Weight Loss System Offers Extra Two Month Supply and Membership for Maximum Weight Loss 2Health News:Carbondale Affordable Assisted Living Community to Host Red Cross Blood Drive 2Health News:Fundamentos de Ayurveda in Mexico (Ayurvedic Principles) Offered by Escuela de Ayurveda de California 2
... threshold of a new era based on better understanding ... each other. There is great potential for exploiting the ... to develop new drugs that act more specifically without ... nature. , A recent workshop on Biosupramolecular Chemistry ...
... The National Lung Cancer Partnership announced today ... Foundation, the Oncology Nursing Society Foundation and the International ... the mission to increase opportunities for lung cancer researchers ... Lung cancer is the leading cancer killer of men ...
... Study found adults ate worse than children did in ... Members of poor households in which it is consistently ... nutritionally risky diets, Canadian researchers reveal. , The new ... directly translates into poor nutrition. It also suggests that ...
... A new take on pilots, health,workplace injuries connected ... studies to be presented at Preventive Medicine 2008,the ... 2008 in Austin, Texas., Long-Haul Flights May ... investigated if acute stress phenomena associated with,frequent take ...
... Lady Laura Bush,today visited the Maamobi Polyclinic in ... two interventions being implemented by AED to control,malaria., ... with Ghana,s commercial,sector to increase the availability and ... in Ghana and five,other sub-Saharan African countries, and ...
... working together to provide dental offices with exposure, to ... Optimizer(R) and other Sikka Software products that assist, dentists and ... financial performance of their practice. Dental Economics will utilize,Sikka Software,s ... ...
Cached Medicine News:Health News:New understanding of how big molecules bind will lead to better drugs, synthetic organic materials 2Health News:New understanding of how big molecules bind will lead to better drugs, synthetic organic materials 3Health News:National Lung Cancer partnership 2Health News:Poverty Drains Nutrition From Family Diet 2Health News:Poverty Drains Nutrition From Family Diet 3Health News:News Briefs from Preventive Medicine 2008 2Health News:News Briefs from Preventive Medicine 2008 3Health News:First Lady Laura Bush Visits AED/Netmark Malaria-Control Project in Ghana 2Health News:Sikka Software and Dental Economics Announce Alliance 2
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
... moderate viscosity and density. Proven ergonomic design reduces hand fatigue, prevents injury. ... (ul) ... 2~5 Imprecision(%) ... 0.01 Dimensions: ...
... the range from 2ul to 5000ul. Fills ... design prevents inadvertent volume change. Novel hand ... pipette is autoclavable at 121C(250F). To prevent ... Suitable for one-handed operation. Auto or Normal ...
... fully adjustable, air-displacement pipette with a patented ... member of the Pipetman family, sharing many ... precision. We also added a number of ... Eight models cover the full range of ...
Medicine Products: